OLAPARIB for Fallopian tube cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 224 adverse event reports in the FDA FAERS database where OLAPARIB was used for Fallopian tube cancer.
Most Reported Side Effects for OLAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 4,378 | 24.0% | 4,377 | 104 |
| Malignant neoplasm progression | 1,862 | 10.2% | 368 | 180 |
| Nausea | 1,582 | 8.7% | 129 | 301 |
| Anaemia | 1,455 | 8.0% | 205 | 469 |
| Fatigue | 1,437 | 7.9% | 101 | 241 |
| Off label use | 777 | 4.3% | 212 | 126 |
| Vomiting | 642 | 3.5% | 82 | 187 |
| Drug ineffective | 563 | 3.1% | 67 | 67 |
| Diarrhoea | 514 | 2.8% | 60 | 131 |
| Asthenia | 491 | 2.7% | 51 | 132 |
| Myelodysplastic syndrome | 466 | 2.6% | 114 | 136 |
| Decreased appetite | 450 | 2.5% | 51 | 121 |
| Disease progression | 423 | 2.3% | 56 | 37 |
| Neuropathy peripheral | 411 | 2.3% | 13 | 38 |
| Haemoglobin decreased | 390 | 2.1% | 34 | 117 |
Other Indications for OLAPARIB
Ovarian cancer (5,923)
Prostate cancer (973)
Breast cancer female (667)
Breast cancer (643)
Ovarian cancer recurrent (515)
Pancreatic carcinoma (475)
Product used for unknown indication (353)
Hormone-refractory prostate cancer (313)
Neoplasm malignant (249)
Ovarian epithelial cancer (219)
Other Drugs Used for Fallopian tube cancer
NIRAPARIB (1,704)
RUCAPARIB CAMSYLATE (385)
BEVACIZUMAB (265)
CARBOPLATIN (228)
PACLITAXEL (216)
DOXORUBICIN (57)
DOCETAXEL (38)
CISPLATIN (27)
ATEZOLIZUMAB (23)
NIVOLUMAB (21)